Trial Watch: Adoptive cell transfer for anticancer immunotherapy.

Oncoimmunology

1 mai 2013
Immune effectors required for the therapeutic activity of vorinostat.

Vacchelli E, Eggermont A, Fridman WH, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.